北米医療大麻市場 – 業界動向と2030年までの予測

Request for TOC TOC のリクエスト Speak to Analyst アナリストに相談する Buy Now今すぐ購入 Inquire Before Buying 事前に問い合わせる Free Sample Report 無料サンプルレポート

北米医療大麻市場 – 業界動向と2030年までの予測

  • Pharmaceutical
  • Published Report
  • May 2023
  • North America
  • 350 ページ
  • テーブル数: 372
  • 図の数: 53

北米医療大麻市場

Market Size in USD Billion

CAGR :  % Diagram

Diagram 予測期間
2024 –2030
Diagram 市場規模(基準年)
USD MILLION
Diagram Market Size (Forecast Year)
USD MILLION
Diagram CAGR
%
Diagram 主要市場プレーヤー
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

>北米医療用大麻市場、製品別(オイル、医療用大麻カプセル、パッチ、全花、粉末花、ベイプペン、乾燥医療用大麻、クリームと保湿剤、マスクと美容液、クレンザーなど)、原料別(天然および合成)、種別(インディカ大麻、サティバ大麻、ハイブリッド大麻)、用途別(アルツハイマー病、食欲不振、がん、炎症性腸疾患、摂食障害、てんかん、自閉症、精神疾患、多発性硬化症、疼痛管理、吐き気、筋けいれん、消耗症候群(悪液質)、気分高揚、うつ病および睡眠障害、不安など)、誘導体別(カンナビジオール(CBD)、テトラヒドロカンナビノール(THC)/デルタ-8-テトラヒドロカンナビノール、カンナビノール(CBN)、カンナビシクロル(CBL)、カンナビクロメン (CBC)、カンナビゲロール (CBG)、その他)、治療タイプ (去痰薬、抗ウイルス薬、鎮痛薬、媚薬、幻覚剤、その他)、投与経路 (経口液剤およびカプセル剤、喫煙、気化器、局所薬、その他)、エンドユーザー (製薬業界、研究開発センター、在宅ケア環境、病院、リハビリセンター、その他)、流通チャネル (B2B および B2C) - 2030 年までの業界動向と予測。

北米医療大麻市場

北米医療大麻市場の分析と洞察

北米における慢性疾患患者数の増加と健康的なライフスタイルへの傾向の高まりは、市場の成長を牽引すると予想される要因の一部です。さらに、医療用大麻機器の製品承認数の増加と研究開発活動の増加が市場の成長を牽引すると予想されます。ただし、医療用大麻機器と手順の高コスト、医薬品、レーザー手順に関連する安全性の懸念と副作用、レーザー機器による治療に関する認識の欠如が、市場の成長を抑制すると予想されます。医療用大麻のさらなる技術的進歩と新興企業による戦略的イニシアチブは、市場成長の機会として機能すると予想されます。ただし、厳格な規制と熟練した専門家の不足が市場の成長に対する課題となることが予想されます。

北米医療大麻市場

北米医療大麻市場

大麻の医薬品としての使用は、政府の規制により厳密にテストされておらず、医療および臨床用途における大麻の有効性を定義する臨床研究は限られています。しかし、予備研究では、大麻は化学療法患者の嘔吐や吐き気を軽減し、食欲を増進させる効果があることが示唆されています。

Data Bridge Market Researchは、北米の医療用大麻市場は2023年から2030年の予測期間中に23.2%のCAGRで成長すると予測していると分析しています。

レポートメトリック

詳細

予測期間

2023年から2030年

基準年

2022

歴史的な年

2021 (2015~2020年にカスタマイズ可能)

定量単位

収益(百万米ドル)

対象セグメント

製品 (オイル、医療用大麻カプセル、パッチ、全花、粉末花、ベイプペン、乾燥医療用大麻、クリームと保湿剤、マスクと美容液、クレンザーなど)、原料 (天然および合成)、種 (大麻インディカ、サティバ、ハイブリッド)、用途 (アルツハイマー病、食欲不振、ガン、炎症性腸疾患、摂食障害、てんかん、自閉症、精神疾患、多発性硬化症、疼痛管理、吐き気、筋肉のけいれん、消耗症候群 (悪液質)、気分の高揚、うつ病および睡眠障害、不安など)、誘導体 (カンナビジオール (CBD)、テトラヒドロカンナビノール (THC)/デルタ-8-テトラヒドロカンナビノール、カンナビノール (CBN)、カンナビシクロール (CBL)、カンナビクロメン (CBC))、カンナビゲロール(CBG)など)、治療タイプ(去痰薬、抗ウイルス薬、鎮痛薬、媚薬、幻覚剤など)、投与経路(経口液剤およびカプセル剤、喫煙、気化器、外用薬など)、エンドユーザー(製薬業界、研究開発センター、在宅ケア環境、病院、リハビリセンターなど)、流通チャネル(B2BおよびB2C)

対象国

米国、カナダ、メキシコ

対象となる市場プレーヤー

MediPharm Labs Inc.、Tilray、Aurora Cannabis、JAZZ Pharmaceuticals Inc. (GW Pharmaceuticals plc)、HEXO Corp. (Zenabis North America Ltd)、Cresco Labs、Peace Naturals Project Inc.、CANO​​PY GROWTH CORPORATION、Medical Marijuana, Inc.、Seed Cellar、EcoGen Biosciences、CANNABIS SEEDS USA、Seeds For Me、HUMBOLDT SEED COMPANY、Extractas、World Class Cannabis Seeds (Crop King Seeds)、BARNEY'S FARM、FOLIUM BIOSCIENCES、PharmaHemp、Elixinol North America Limited、ENDOCA、Harmony、MARY'S nutritionals, LLC、Pure Ratios、Greenwich Biosciences, Inc.、Upstate Elevator Supply Co.、Apothecanna、BOL Pharma、IDT Australia など

市場の定義

大麻はアサ科の植物から抽出される向精神薬です。長年にわたり医療用として使用され、慢性疼痛、癌、うつ病、糖尿病、関節炎、緑内障、てんかん、偏頭痛、エイズ、アルツハイマー病など、さまざまな病気の治療に幅広く応用されています。

大麻の医療用途の増加、さまざまな業界での大麻の管理された合法化と使用、およびこの分野に存在する高度な方法論は、市場の成長を促進すると予想される要因の一部です。

北米医療大麻市場の動向

このセクションでは、市場の推進要因、利点、機会、制約、課題について理解します。これらはすべて、以下のように詳細に説明されます。

ドライバー

  • 医薬品としての大麻の使用増加

医療用大麻は大麻植物から抽出され、特定の病状の症状や一部の治療の副作用の治療に使用できます。大麻の医療用途として最も一般的なのは、痛みの管理です。さまざまな適応症で大麻の使用を合法化する国が増え、医療用大麻は徐々に受け入れられ、使用されるようになっています。医療用大麻は、まれで重篤なてんかん、ドラベ症候群、レノックス・ガストー症候群の 3 つの適応症、および多発性硬化症 (MS) の痙縮の治療に FDA によって承認されています。

医療用マリファナは、承認された医薬品とは別に、病気や症状の治療にマリファナ植物またはその中の化学物質を使用しますが、デルタ-9-テトラヒドロカンナビノールとカンナビジオールという 2 つのカンナビノイドへの関心が高まっています。テトラヒドロカンナビノールは食欲を増進し、疲労を最小限に抑え、筋肉機能の問題を管理することが示されており、カンナビジオールはてんかん発作の管理、精神疾患の治療、炎症の軽減に効果的です。

  • 大麻の合法化

医療用大麻の使用と受容は進化を続けており、特定の医療適応症の使用を許可する州が増えています。多くの国では医療目的または娯楽目的でマリファナを合法化していますが、使用を制限している国もあります。近年、米国では医療目的または娯楽目的でマリファナを合法化する州が増えています。大麻の合法化が広まるにつれ、多くの企業も積極的になり、大麻の完全合法化に向けた取り組みを行っています。

世界各地でマリファナが合法化されているのは、追加収入を増やすための取り組みと見ることができます。こうすることで、税金を上げずに収入を増やすことができます。大麻の合法化により、医療目的または娯楽目的での大麻の消費が増えることになります。さらに、大麻ビジネスも促進され、大麻の需要が高まります。したがって、大麻の合法化は市場の成長を促進すると予想されます。

機会

  • 研究開発活動の増加による新製品開発

医療用大麻には、カプセル、チューイングガム、クリーム、結晶、花、トローチ、オイル、口腔粘膜スプレーなど、さまざまな形態があります。合法化に伴う大麻の需要の急成長により、より優れた製品株とデリバリーシステムの開発の必要性が高まっています。このため、多くの企業が大麻の遺伝的改良戦略を確認するための研究開発活動を行っています。FDA の大麻製品委員会 (CPC) は、大麻製品の規制に関する省庁横断的な戦略とポリシーを策定し、実施しています。開発され、増加している新しい製品は、ヘンププロテインパウダー、エナジーバー、ヘンプミルク、ヘンプフラワー、ヘンプティーで、市場成長の機会を生み出すことが期待されています。

  • 娯楽目的での大麻の採用増加

娯楽用マリファナの合法化は、潜在的な悪影響を増やすことなく、安全な薬物の規制に役立ちます。マリファナの合法化は、税金を増やすことなく経済を成長させ、何千もの雇用機会を創出し、マリファナの取り締まりにおける人種の違いをなくし、希少な警察資源を解放するなど、さまざまな社会的利益をもたらします。娯楽用マリファナの合法化は、費用のかかるマリファナ法の取り締まりを終わらせ、違法マリファナ市場を弱体化させることができます。

これらの利点により、マリファナは合法化され、さまざまな年齢層の人々にますます受け入れられています。これにより、楽しみとリラクゼーションのための良質のマリファナの需要が生まれます。したがって、娯楽目的での大麻の採用の増加は、市場でメーカーにチャンスを生み出すと予想されます。

抑制/挑戦

  • 高額な購入と高品質への急ぎ

医療用大麻デバイスは製造と購入に費用がかかる場合があり、特殊な機器とトレーニングが必要なため、処置費用も高額になる可能性があります。これにより、特に低所得地域では、患者と医療施設が医療用大麻治療を受けにくくなる可能性があります。さらに、医療用大麻デバイスと処置の費用が高いため、特に自費で支払わなければならない場合、一部の患者はこれらの治療を選択することを思いとどまる可能性があります。医療用大麻治療に対する保険適用も限られているため、採用が制限される可能性があります。

その結果、医療用大麻の機器や処置にかかるコストの高さは、特にコストが大きな要因となっている地域では、市場の成長に対する大きな障壁となる可能性があります。しかし、技術が進歩するにつれて、これらの機器や処置にかかるコストは下がり、患者や医療施設にとってより利用しやすくなる可能性があります。

医療用大麻機器の複雑化と医療用大麻治療の高コストにより、市場の成長が抑制されると予想されます。

最近の開発

  • 2018 年 5 月、カナダ政府の大麻法に基づき、大麻法により、カナダ全土での大麻の生産、流通、販売、所持を規制するための厳格な法的枠組みが構築されます。これは、法的に規制された強固な産業を育成することで、大麻が若者の手に渡らないようにし、組織犯罪の利益が大麻に流れないようにすることを目的としています。

北米医療大麻市場の範囲

北米の医療用大麻市場は、製品、供給源、種、派生物、用途、投与経路、治療タイプ、エンドユーザー、流通チャネルに基づいて、9 つの主要なセグメントに分割されています。これらのセグメントの成長は、業界の市場成長セグメントの分析に役立ち、ユーザーに貴重な市場概要と市場洞察を提供して、コア市場アプリケーションを特定するための戦略的決定を下すのに役立ちます。

製品

  • 乾燥医療用大麻
  • 医療用大麻カプセル
  • ベイプペン
  • 花全体
  • クリーム&保湿剤
  • グラウンドフラワー
  • パッチ
  • マスク&美容液
  • クレンザー
  • その他

製品に基づいて、市場はオイル、医療用大麻カプセル、パッチ、全花、粉末花、ベイプペン、乾燥医療用大麻、クリームと保湿剤、マスクと美容液、クレンザー、その他に分類されます

ソース

  • 合成
  • 自然

供給源に基づいて、市場は合成と天然に分類されます。

  • 大麻インディカ
  • サティバ
  • ハイブリッド

種に基づいて、市場は大麻のインディカ、サティバ、ハイブリッドに分類されます。

デリバティブ

  • カンナビジオール(CBD)
  • テトラヒドロカンナビノール (THC)/デルタ-8-テトラヒドロカンナビノール
  • カンナビゲロール(CBG)
  • カンナビクロメン(CBC)
  • カンナビノール(CBN)
  • カンナビシクロロール (CBL)
  • その他

誘導体に基づいて、市場はカンナビジオール(CBD)、テトラヒドロカンナビノール(THC)/デルタ-8-テトラヒドロカンナビノール、カンナビノール(CBN)、カンナビシクロール(CBL)、カンナビクロメン(CBC)、カンナビゲロール(CBG)などに分類されます。

応用

  • 疼痛管理
  • 不安
  • 筋けいれん
  • 吐き気
  • 食欲不振
  • 摂食障害
  • 炎症性腸疾患
  • 関節炎
  • 消耗症候群(悪液質)
  • アルツハイマー病
  • てんかん
  • うつ病と睡眠障害
  • 多発性硬化症
  • 自閉症
  • 精神衛生状態
  • 気分を高める
  • その他

用途に基づいて、市場はアルツハイマー病、食欲不振、癌、炎症性腸疾患、摂食障害、てんかん、自閉症、精神疾患、多発性硬化症、疼痛管理、吐き気、筋肉のけいれん、消耗症候群(悪液質)、気分の高揚、多発性硬化症、うつ病および睡眠障害、不安症などに分類されます。

投与経路

  • 経口液剤とカプセル剤
  • 喫煙
  • 気化器
  • 局所用薬
  • その他

投与経路に基づいて、市場は経口液剤とカプセル剤、喫煙、気化器、局所薬、その他に分類されます。

治療の種類

  • 鎮痛剤
  • サイケデリック
  • 抗ウィルス薬
  • 媚薬
  • 去痰薬
  • その他

治療の種類に基づいて、市場は去痰薬、抗ウイルス薬、鎮痛薬、媚薬、幻覚剤、その他に分類されます。

エンドユーザー

  • 在宅ケア環境
  • 病院
  • リハビリセンター
  • 製薬業界
  • 研究開発センター
  • その他

エンドユーザーに基づいて、市場は製薬業界、研究開発センター、在宅ケア環境、病院、リハビリセンター、その他に分類されます。

流通チャネル

  • 企業向け
  • B2C

流通チャネルに基づいて、市場は B2B と B2C に分類されます。

アジア太平洋地域の医療用大麻市場

北米医療大麻市場の地域分析/洞察

北米の医療用大麻市場は、製品、供給元、種、派生物、用途、投与経路、治療タイプ、エンドユーザー、流通チャネルに基づいて、9 つの主要なセグメントに分割されています。

この市場レポートで取り上げられている国は、米国、カナダ、メキシコです。

医療用大麻の使用が合法化されたことにより、米国は北米の医療用大麻市場を支配すると予想されています。

レポートの国別セクションでは、市場の現在および将来の傾向に影響を与える国内市場における個別の市場影響要因と規制の変更も提供しています。新規販売、交換販売、国の人口統計、規制行為、輸出入関税などのデータ ポイントは、各国の市場シナリオを予測するために使用される主要な指標の一部です。また、国別データの予測分析を提供する際には、地域ブランドの存在と可用性、地元および国内ブランドとの競争が激しいか少ないために直面​​する課題、販売チャネルの影響も考慮されます。

競争環境と北米医療大麻市場シェア分析

北米医療大麻市場の競争状況は、競合他社の詳細を提供します。会社概要、会社の財務状況、収益、市場の可能性、研究開発への投資、新しい市場への取り組み、地域的プレゼンス、生産拠点と施設、会社の強みと弱み、製品の発売、臨床試験パイプライン、ブランド分析、製品承認、特許、製品の幅と広さ、アプリケーションの優位性、および技術ライフライン曲線などの詳細が含まれます。上記のデータ ポイントは、市場に関連する会社の焦点にのみ関連しています。

この市場で活動している主要な市場プレーヤーには、MediPharm Labs Inc.、Tilray、Aurora Cannabis、JAZZ Pharmaceuticals Inc. (GW Pharmaceuticals plc)、HEXO Corp. (Zenabis North America Ltd)、Cresco Labs、Peace Naturals Project Inc.、CANO​​PY GROWTH CORPORATION、Medical Marijuana, Inc.、Seed Cellar、EcoGen Biosciences、CANNABIS SEEDS USA、Seeds For Me、HUMBOLDT SEED COMPANY、Extractas、World Class Cannabis Seeds (Crop King Seeds)、BARNEY'S FARM、FOLIUM BIOSCIENCES、PharmaHemp、Elixinol North America Limited、ENDOCA、Harmony、MARY'S nutritionals, LLC、Pure Ratios、Greenwich Biosciences, Inc.、Upstate Elevator Supply Co.、Apothecanna、BOL Pharma、IDT Australia などがあります。


SKU-

世界初のマーケットインテリジェンスクラウドに関するレポートにオンラインでアクセスする

  • インタラクティブなデータ分析ダッシュボード
  • 成長の可能性が高い機会のための企業分析ダッシュボード
  • カスタマイズとクエリのためのリサーチアナリストアクセス
  • インタラクティブなダッシュボードによる競合分析
  • 最新ニュース、更新情報、トレンド分析
  • 包括的な競合追跡のためのベンチマーク分析のパワーを活用
デモのリクエスト

目次

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE NORTH AMERICA MEDICAL CANNABIS MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 PRODUCT LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 MARKET APPLICATION COVERAGE GRID

2.11 VENDOR SHARE ANALYSIS

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTEL ANALYSIS

4.2 PORTER’S FIVE FORCES

5 INDUSTRY INSIGHTS

5.1 INDUSTRY INSIGHTS PATENT ANALYSIS

5.2 DRUG TREATMENT RATE BY MATURED MARKETS

5.3 DEMOGRAPHIC TRENDS: IMPACTS ON ALL INCIDENCE RATES

5.4 PATIENT FLOW DIAGRAM

5.5 KEY PRICING STRATEGIES

5.6 KEY PATIENT ENROLLMENT STRATEGIES

6 REGULATORY SCENARIO

6.1 U.S.

6.2 CANADA

6.3 MEXICO

7 MARKET OVERVIEW

7.1 DRIVERS

7.1.1 INCREASED USE OF CANNABIS IN MEDICINES

7.1.2 LEGALIZATION OF CANNABIS

7.1.3 STRATEGIC INITIATIVES TAKEN BY KEY PLAYERS

7.1.4 RISE IN THE PREVALENCE OF DISEASES THAT REQUIRE THE USE OF CANNABIS

7.2 RESTRAINTS

7.2.1 COMPLEX REGULATORY STRUCTURE FOR THE USAGE OF CANNABIS

7.2.2 ADVERSE EFFECTS DUE TO LONG-TERM USE

7.2.3 HIGH-COST PURCHASING AND RUSH FOR PREMIUM QUALITY

7.3 OPPORTUNITIES

7.3.1 NOVEL PRODUCT DEVELOPMENT WITH INCREASING R&D ACTIVITIES

7.3.2 INCREASED ADOPTION OF CANNABIS FOR RECREATIONAL PURPOSES

7.3.3 GROWING GERIATRIC POPULATION

7.4 CHALLENGES

7.4.1 RISE OF THE CANNABIS BLACK MARKET

7.4.2 SIDE EFFECTS RELATED TO THE USE OF CANNABIS

7.4.3 SHORTAGE OF SKILLED PERSONNEL

8 NORTH AMERICA MEDICAL CANNABIS MARKET, BY PRODUCT

8.1 OVERVIEW

8.2 OIL

8.2.1 OIL, BY TYPE

8.2.1.1 CBD OIL CONCENTRATES

8.2.1.2 CBD VAPE OIL

8.2.1.3 CBD TINCTURES

8.2.2 OIL, BY SOURCE

8.2.2.1 HEMP BASED

8.2.2.2 MARIJUANA BASED

8.2.3 OIL, BY SPECIES

8.2.3.1 SATIVA

8.2.3.2 HYBRID

8.2.3.3 CANNABIS INDICA

8.2.4 OIL, BY PRODUCT TYPE

8.2.4.1 BRANDED

8.2.4.1.1 PENGUIN CBD OIL

8.2.4.1.2 FAB CBD OIL

8.2.4.1.3 GREEN ROADS BROAD SPECTRUM CBD OIL

8.2.4.1.4 OTHERS

8.2.4.2 GENERIC

8.3 DRIED MEDICAL CANNABIS

8.3.1 CANNABIS INDICA

8.3.2 SATIVA

8.3.3 HYBRID

8.4 MEDICAL CANNABIS CAPSULES

8.4.1 MEDICAL CANNABIS CAPSULES, BY TYPE

8.4.1.1 OIL BASED CANNABIS CAPSULES

8.4.1.2 POWDER BASED CANNABIS CAPSULES

8.4.1.3 LIQUID BASED CANNABIS CAPSULES

8.4.1.4 OTHERS

8.4.2 MEDICAL CANNABIS CAPSULES, BY CONCENTRATES

8.4.2.1 HIGH CBD CAPSULES DIGITAL

8.4.2.2 HIGH THC CAPSULE

8.4.2.3 THC/CBD BALANCED CAPSULE

8.4.2.4 CBD ISOLATE CAPSULE

8.4.3 MEDICAL CANNABIS CAPSULES, BY SPECIES

8.4.3.1 SATIVA

8.4.3.2 CANNABIS INDICA

8.4.4 MEDICAL CANNABIS CAPSULES, BY PRODUCT TYPE

8.4.4.1 BRANDED

8.4.4.1.1 JOY NUTRITION

8.4.4.1.2 MEDTERRA ISOLATE CBD GEL CAPSULES

8.4.4.1.3 LAZARUS NATURALS

8.4.4.1.4 OTHERS

8.4.4.2 GENERIC

8.5 VAPE PEN

8.5.1 VAPE PEN, BY SPECIES

8.5.1.1 SATIVA

8.5.1.2 HYBRID

8.5.1.3 CANNABIS INDICA

8.5.2 VAPE PEN, BY PRODUCT TYPE

8.5.2.1 BRANDED

8.5.2.1.1 KANDYPENS RUBI

8.5.2.1.2 SOL E-NECTAR COLLECTOR

8.5.2.1.3 PAX ERA PRO-OIL VAPE PEN

8.5.2.2 GENERIC

8.6 WHOLE FLOWER

8.6.1 WHOLE FLOWER, SPECIES

8.6.1.1 SATIVA

8.6.1.2 HYBRID

8.6.1.3 CANNABIS INDICA

8.6.2 WHOLE FLOWER, PRODUCT TYPE

8.6.2.1 BRANDED

8.6.2.1.1 ASTER FARMS

8.6.2.1.2 RA FLOWER

8.6.2.1.3 BAD APPLE

8.6.2.2 GENERIC

8.7 CREAMS & MOISTURIZER

8.7.1 CREAMS & MOISTURIZER, BY SPECIES

8.7.1.1 SATIVA

8.7.1.2 HYBRID

8.7.1.3 CANNABIS INDICA

8.7.2 CREAMS & MOISTURIZER, BY PRODUCT TYPE

8.7.2.1 BRANDED

8.7.2.1.1 CBDFX MUSCLE & JOINT

8.7.2.1.2 ASPEN GREEN MUSCLE RELIEF COOLING CREAM

8.7.2.1.3 MEDTERRA PAIN CREAM

8.7.2.2 GENERIC

8.8 GROUND FLOWER

8.8.1 GROUND FLOWER, BY SPECIES

8.8.1.1 SATIVA

8.8.1.2 HYBRID

8.8.1.3 CANNABIS INDICA

8.8.2 GROUND FLOWER, BY PRODUCT TYPE

8.8.2.1 BRANDED

8.8.2.1.1 ASTER FARMS

8.8.2.1.2 RA FLOWER

8.8.2.1.3 BAD APPLE

8.8.2.2 GENERIC

8.9 PATCH

8.9.1 PATCH, BY TYPE

8.9.1.1 RESERVOIR

8.9.1.2 LAYER DRUG-IN-ADHESIVE

8.9.1.3 OTHERS

8.9.2 PATCH, BY SPECIES

8.9.2.1 SATIVA

8.9.2.2 CANNABIS INDICA

8.9.2.3 HYBRID

8.9.3 PATCH, BY PRODUCT TYPE

8.9.3.1 BRANDED

8.9.3.1.1 HEMP BOMBS

8.9.3.1.2 PUREKANA

8.9.3.1.3 PURE RATIOS

8.9.3.1.4 RESERVOIR

8.9.3.2 GENERIC

8.1 MASKS & SERUM

8.10.1 MASKS & SERUM, BY SPECIES

8.10.1.1 SATIVA

8.10.1.2 CANNABIS INDICA

8.10.1.3 HYBRID

8.10.2 MASKS & SERUM, BY PRODUCT TYPE

8.10.2.1 BRANDED

8.10.2.1.1 BUMP & SMOOTH CBD

8.10.2.1.2 FACIAL ESSENCE

8.10.2.1.3 OTHERS

8.10.2.2 GENERIC

8.11 CLEANSER

8.11.1 CLEANSER, BY SPECIES

8.11.1.1 SATIVA

8.11.1.2 HYBRID

8.11.1.3 CANNABIS INDICA

8.11.2 CLEANSER, BY PRODUCT TYPE

8.11.2.1 BRANDED

8.11.2.1.1 KIEHL’S

8.11.2.1.2 CBD 101

8.11.2.1.3 OTHERS

8.11.2.2 GENERIC

8.12 OTHERS

9 NORTH AMERICA MEDICAL CANNABIS MARKET, BY SPECIES

9.1 OVERVIEW

9.2 SATIVA

9.3 HYBRID

9.4 CANNABIS INDICA

10 NORTH AMERICA MEDICAL CANNABIS MARKET, BY DERIVATIVES

10.1 OVERVIEW

10.2 CANNABIDIOL (CBD)

10.3 TETRAHYDROCANNABINOL (THC)/DELTA-8-TETRAHYDROCANNABINOL

10.4 CANNABIGEROL (CBG)

10.5 CANNABICHROMENE (CBC)

10.6 CANNABINOL (CBN)

10.7 CANNABICYCLOL (CBL)

10.8 OTHERS

11 NORTH AMERICA MEDICAL CANNABIS MARKET, BY APPLICATION

11.1 OVERVIEW

11.2 PAIN MANAGEMENT

11.2.1 PAIN MANAGEMENT, BY TYPE

11.2.1.1 CHRONIC PAIN

11.2.1.2 NON-CANCER CHRONIC PAIN

11.2.1.3 NEUROLOGICAL PAIN

11.2.2 PAIN MANAGEMENT, BY PRODUCT

11.2.2.1 OIL

11.2.2.2 DRIED MEDICAL CANNABIS

11.2.2.3 MEDICAL CANNABIS CAPSULES

11.2.2.4 PATCH

11.2.2.5 GROUND FLOWER

11.2.2.6 CREAMS & MOISTURIZER

11.2.2.7 VAPE PEN

11.2.2.8 WHOLE FLOWER

11.2.2.9 MASKS & SERUM

11.2.2.10 CLEANSER

11.2.2.11 OTHERS

11.3 ANXIETY

11.3.1 OIL

11.3.2 DRIED MEDICAL CANNABIS

11.3.3 MEDICAL CANNABIS CAPSULES

11.3.4 PATCH

11.3.5 GROUND FLOWER

11.3.6 CREAMS & MOISTURIZER

11.3.7 VAPE PEN

11.3.8 WHOLE FLOWER

11.3.9 MASKS & SERUM

11.3.10 CLEANSER

11.3.11 OTHERS

11.4 MUSCLE SPASM

11.4.1 OIL

11.4.2 DRIED MEDICAL CANNABIS

11.4.3 MEDICAL CANNABIS CAPSULES

11.4.4 PATCH

11.4.5 GROUND FLOWER

11.4.6 CREAMS & MOISTURIZER

11.4.7 VAPE PEN

11.4.8 WHOLE FLOWER

11.4.9 MASKS & SERUM

11.4.10 CLEANSER

11.4.11 OTHERS

11.5 NAUSEA

11.5.1 OIL

11.5.2 DRIED MEDICAL CANNABIS

11.5.3 MEDICAL CANNABIS CAPSULES

11.5.4 PATCH

11.5.5 GROUND FLOWER

11.5.6 CREAMS & MOISTURIZER

11.5.7 VAPE PEN

11.5.8 WHOLE FLOWER

11.5.9 MASKS & SERUM

11.5.10 CLEANSER

11.5.11 OTHERS

11.6 APPETITE LOSS

11.6.1 OIL

11.6.2 DRIED MEDICAL CANNABIS

11.6.3 MEDICAL CANNABIS CAPSULES

11.6.4 PATCH

11.6.5 GROUND FLOWER

11.6.6 CREAMS & MOISTURIZER

11.6.7 VAPE PEN

11.6.8 WHOLE FLOWER

11.6.9 MASKS & SERUM

11.6.10 CLEANSER

11.6.11 OTHERS

11.7 EATING DISORDERS

11.7.1 OIL

11.7.2 DRIED MEDICAL CANNABIS

11.7.3 MEDICAL CANNABIS CAPSULES

11.7.4 PATCH

11.7.5 GROUND FLOWER

11.7.6 CREAMS & MOISTURIZER

11.7.7 VAPE PEN

11.7.8 WHOLE FLOWER

11.7.9 MASKS & SERUM

11.7.10 CLEANSER

11.7.11 OTHERS

11.8 INFLAMMATORY BOWEL DISEASES

11.8.1 OIL

11.8.2 DRIED MEDICAL CANNABIS

11.8.3 MEDICAL CANNABIS CAPSULES

11.8.4 PATCH

11.8.5 GROUND FLOWER

11.8.6 CREAMS & MOISTURIZER

11.8.7 VAPE PEN

11.8.8 WHOLE FLOWER

11.8.9 MASKS & SERUM

11.8.10 CLEANSER

11.8.11 OTHERS

11.9 CANCER

11.9.1 OIL

11.9.2 DRIED MEDICAL CANNABIS

11.9.3 MEDICAL CANNABIS CAPSULES

11.9.4 PATCH

11.9.5 GROUND FLOWER

11.9.6 CREAMS & MOISTURIZER

11.9.7 VAPE PEN

11.9.8 WHOLE FLOWER

11.9.9 MASKS & SERUM

11.9.10 CLEANSER

11.9.11 OTHERS

11.1 ARTHRITIS

11.10.1 OIL

11.10.2 DRIED MEDICAL CANNABIS

11.10.3 MEDICAL CANNABIS CAPSULES

11.10.4 PATCH

11.10.5 GROUND FLOWER

11.10.6 CREAMS & MOISTURIZER

11.10.7 VAPE PEN

11.10.8 WHOLE FLOWER

11.10.9 MASKS & SERUM

11.10.10 CLEANSER

11.10.11 OTHERS

11.11 WASHING SYNDROME (CACHEXIA)

11.11.1 OIL

11.11.2 DRIED MEDICAL CANNABIS

11.11.3 MEDICAL CANNABIS CAPSULES

11.11.4 PATCH

11.11.5 GROUND FLOWER

11.11.6 CREAMS & MOISTURIZER

11.11.7 VAPE PEN

11.11.8 WHOLE FLOWER

11.11.9 MASKS & SERUM

11.11.10 CLEANSER

11.11.11 OTHERS

11.12 ALZHEIMER’S DISEASE

11.12.1 OIL

11.12.2 DRIED MEDICAL CANNABIS

11.12.3 MEDICAL CANNABIS CAPSULES

11.12.4 PATCH

11.12.5 GROUND FLOWER

11.12.6 CREAMS & MOISTURIZER

11.12.7 VAPE PEN

11.12.8 WHOLE FLOWER

11.12.9 MASKS & SERUM

11.12.10 CLEANSER

11.12.11 OTHERS

11.13 EPILEPSY

11.13.1 OIL

11.13.2 DRIED MEDICAL CANNABIS

11.13.3 MEDICAL CANNABIS CAPSULES

11.13.4 PATCH

11.13.5 GROUND FLOWER

11.13.6 CREAMS & MOISTURIZER

11.13.7 VAPE PEN

11.13.8 WHOLE FLOWER

11.13.9 MASKS & SERUM

11.13.10 CLEANSER

11.13.11 OTHERS

11.14 DEPRESSION AND SLEEP DISORDER

11.14.1 OIL

11.14.2 DRIED MEDICAL CANNABIS

11.14.3 MEDICAL CANNABIS CAPSULES

11.14.4 PATCH

11.14.5 GROUND FLOWER

11.14.6 CREAMS & MOISTURIZER

11.14.7 VAPE PEN

11.14.8 WHOLE FLOWER

11.14.9 MASKS & SERUM

11.14.10 CLEANSER

11.14.11 OTHERS

11.15 MULTIPLE SCLEROSIS

11.15.1 OIL

11.15.2 DRIED MEDICAL CANNABIS

11.15.3 MEDICAL CANNABIS CAPSULES

11.15.4 PATCH

11.15.5 GROUND FLOWER

11.15.6 CREAMS & MOISTURIZER

11.15.7 VAPE PEN

11.15.8 WHOLE FLOWER

11.15.9 MASKS & SERUM

11.15.10 CLEANSER

11.15.11 OTHERS

11.16 AUTISM

11.16.1 OIL

11.16.2 DRIED MEDICAL CANNABIS

11.16.3 MEDICAL CANNABIS CAPSULES

11.16.4 PATCH

11.16.5 GROUND FLOWER

11.16.6 CREAMS & MOISTURIZER

11.16.7 VAPE PEN

11.16.8 WHOLE FLOWER

11.16.9 MASKS & SERUM

11.16.10 CLEANSER

11.16.11 OTHERS

11.17 MENTAL HEALTH CONDITIONS

11.17.1 MENTAL HEALTH CONDITIONS, BY TYPE

11.17.1.1 POSTTRAUMATIC STRESS DISORDER (PTSD)

11.17.1.2 SCHIZOPHRENIA

11.17.1.3 OTHERS

11.17.2 MENTAL HEALTH CONDITIONS, BY TYPE

11.17.2.1 OIL

11.17.2.2 DRIED MEDICAL CANNABIS

11.17.2.3 MEDICAL CANNABIS CAPSULES

11.17.2.4 PATCH

11.17.2.5 GROUND FLOWER

11.17.2.6 CREAMS & MOISTURIZER

11.17.2.7 VAPE PEN

11.17.2.8 WHOLE FLOWER

11.17.2.9 MASKS & SERUM

11.17.2.10 CLEANSER

11.17.2.11 OTHERS

11.18 ELEVATE MOOD

11.18.1 OIL

11.18.2 DRIED MEDICAL CANNABIS

11.18.3 MEDICAL CANNABIS CAPSULES

11.18.4 PATCH

11.18.5 GROUND FLOWER

11.18.6 CREAMS & MOISTURIZER

11.18.7 VAPE PEN

11.18.8 WHOLE FLOWER

11.18.9 MASKS & SERUM

11.18.10 CLEANSER

11.18.11 OTHERS

11.19 OTHERS

12 NORTH AMERICA MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION

12.1 OVERVIEW

12.2 ORAL SOLUTIONS AND CAPSULES

12.3 SMOKING

12.4 TOPICALS

12.5 VAPORIZERS

12.6 OTHERS

13 NORTH AMERICA MEDICAL CANNABIS MARKET, BY TREATMENT TYPE

13.1 OVERVIEW

13.2 ANALGESIC

13.3 PSYCHEDELIC

13.4 ANTIVIRAL

13.5 APHRODISIAC

13.6 EXPECTORANT

13.7 OTHERS

14 NORTH AMERICA MEDICAL CANNABIS MARKET, BY END USER

14.1 OVERVIEW

14.2 HOMECARE SETTING

14.3 HOSPITAL

14.4 REHAB CENTERS

14.5 PHARMACEUTICAL INDUSTRY

14.6 RESEARCH AND DEVELOPMENT CENTERS

14.7 OTHERS

15 NORTH AMERICA MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL

15.1 OVERVIEW

15.2 B2C

15.2.1 PHARMACIES

15.2.2 CONVENTIONAL STORES

15.2.3 ONLINE STORES

15.2.4 OTHERS

15.3 B2B

16 NORTH AMERICA MEDICAL CANNABIS MARKET, BY REGION

16.1 NORTH AMERICA

16.1.1 U.S.

16.1.2 CANADA

16.1.3 MEXICO

17 NORTH AMERICA MEDICAL CANNABIS MARKET: COMPANY LANDSCAPE

17.1 COMPANY SHARE ANALYSIS: NORTH AMERICA

18 COMPANY PROFILE

18.1 MEDIPHARM LABS INC.

18.1.1 COMPANY SNAPSHOT

18.1.2 REVENUE ANALYSIS

18.1.3 COMPANY SHARE ANALYSIS

18.1.4 PRODUCT PORTFOLIO

18.1.5 RECENT DEVELOPMENTS

18.2 TILRAY

18.2.1 COMPANY SNAPSHOT

18.2.2 COMPANY SHARE ANALYSIS

18.2.3 PRODUCT PORTFOLIO

18.2.4 RECENT DEVELOPMENTS

18.3 AURORA CANNABIS

18.3.1 COMPANY SNAPSHOT

18.3.2 REVENUE ANALYSIS

18.3.3 COMPANY SHARE ANALYSIS

18.3.4 PRODUCT PORTFOLIO

18.3.5 RECENT DEVELOPMENTS

18.4 JAZZ PHARMACEUTICALS INC. (GW PHARMACEUTICALS PLC)

18.4.1 COMPANY SNAPSHOT

18.4.2 REVENUE ANALYSIS

18.4.3 COMPANY SHARE ANALYSIS

18.4.4 PRODUCT PORTFOLIO

18.4.5 RECENT DEVELOPMENTS

18.5 HEXO CORP. (ZENABIS NORTH AMERICA LTD)

18.5.1 COMPANY SNAPSHOT

18.5.2 REVENUE ANALYSIS

18.5.3 COMPANY SHARE ANALYSIS

18.5.4 PRODUCT PORTFOLIO

18.5.5 RECENT DEVELOPMENTS

18.6 APOTHECANNA

18.6.1 COMPANY SNAPSHOT

18.6.2 PRODUCT PORTFOLIO

18.6.3 RECENT DEVELOPMENT

18.7 BOL PHARMA

18.7.1 COMPANY SNAPSHOT

18.7.2 PRODUCT PORTFOLIO

18.7.3 RECENT DEVELOPMENTS

18.8 BARNEY’S FARM

18.8.1 COMPANY SNAPSHOT

18.8.2 PRODUCT PORTFOLIO

18.8.3 RECENT DEVELOPMENTS

18.9 CANOPY GROWTH CORPORATION

18.9.1 COMPANY SNAPSHOT

18.9.2 REVENUE ANALYSIS

18.9.3 PRODUCT PORTFOLIO

18.9.4 RECENT DEVELOPMENTS

18.1 CANNABIS SEEDS USA

18.10.1 COMPANY SNAPSHOT

18.10.2 PRODUCT PORTFOLIO

18.10.3 RECENT DEVELOPMENT

18.11 CRESCO LABS

18.11.1 COMPANY SNAPSHOT

18.11.2 PRODUCT PORTFOLIO

18.11.3 RECENT DEVELOPMENTS

18.12 ECOGEN BIOSCIENCES

18.12.1 COMPANY SNAPSHOT

18.12.2 PRODUCT PORTFOLIO

18.12.3 RECENT DEVELOPMENTS

18.13 ELIXINOL NORTH AMERICA LIMITED

18.13.1 COMPANY SNAPSHOT

18.13.2 REVENUE ANALYSIS

18.13.3 PRODUCT PORTFOLIO

18.13.4 RECENT DEVELOPMENTS

18.14 ENDOCA

18.14.1 COMPANY SNAPSHOT

18.14.2 PRODUCT PORTFOLIO

18.14.3 RECENT DEVELOPMENT

18.15 EXTRACTAS

18.15.1 COMPANY SNAPSHOT

18.15.2 PRODUCT PORTFOLIO

18.15.3 RECENT DEVELOPMENT

18.16 FOLIUM BIOSCIENCES

18.16.1 COMPANY SNAPSHOT

18.16.2 PRODUCT PORTFOLIO

18.16.3 RECENT DEVELOPMENTS

18.17 GREENWICH BIOSCIENCES, INC.

18.17.1 COMPANY SNAPSHOT

18.17.2 PRODUCT PORTFOLIO

18.17.3 RECENT DEVELOPMENTS

18.18 HARMONY

18.18.1 COMPANY SNAPSHOT

18.18.2 PRODUCT PORTFOLIO

18.18.3 RECENT DEVELOPMENTS

18.19 HUMBOLDT SEED COMPANY

18.19.1 COMPANY SNAPSHOT

18.19.2 PRODUCT PORTFOLIO

18.19.3 RECENT DEVELOPMENT

18.2 IDT AUSTRALIA

18.20.1 COMPANY SNAPSHOT

18.20.2 REVENUE ANALYSIS

18.20.3 PRODUCT PORTFOLIO

18.20.4 RECENT DEVELOPMENTS

18.21 MARY’S NUTRITIONALS, LLC

18.21.1 COMPANY SNAPSHOT

18.21.2 PRODUCT PORTFOLIO

18.21.3 RECENT DEVELOPMENT

18.22 MEDICAL MARIJUANA, INC.

18.22.1 COMPANY SNAPSHOT

18.22.2 REVENUE ANALYSIS

18.22.3 PRODUCT PORTFOLIO

18.22.4 RECENT DEVELOPMENTS

18.23 PEACE NATURALS PROJECT INC.

18.23.1 COMPANY SNAPSHOT

18.23.2 PRODUCT PORTFOLIO

18.23.3 RECENT DEVELOPMENT

18.24 PHARMAHEMP

18.24.1 COMPANY SNAPSHOT

18.24.2 PRODUCT PORTFOLIO

18.24.3 RECENT DEVELOPMENT

18.25 PURE RATIOS

18.25.1 COMPANY SNAPSHOT

18.25.2 PRODUCT PORTFOLIO

18.25.3 RECENT DEVELOPMENT

18.26 SEEDS FOR ME

18.26.1 COMPANY SNAPSHOT

18.26.2 PRODUCT PORTFOLIO

18.26.3 RECENT DEVELOPMENT

18.27 SEED CELLAR

18.27.1 COMPANY SNAPSHOT

18.27.2 PRODUCT PORTFOLIO

18.27.3 RECENT DEVELOPMENT

18.28 UPSTATE ELEVATOR SUPPLY CO.

18.28.1 COMPANY SNAPSHOT

18.28.2 PRODUCT PORTFOLIO

18.28.3 RECENT DEVELOPMENT

18.29 WORLD CLASS CANNABIS SEEDS (CROP KING SEEDS)

18.29.1 COMPANY SNAPSHOT

18.29.2 PRODUCT PORTFOLIO

18.29.3 RECENT DEVELOPMENT

19 QUESTIONNAIRE

20 RELATED REPORTS

表のリスト

TABLE 1 NORTH AMERICA MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)

TABLE 2 NORTH AMERICA OIL IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 3 NORTH AMERICA OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 4 NORTH AMERICA OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 5 NORTH AMERICA OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 6 NORTH AMERICA OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION)

TABLE 7 NORTH AMERICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 8 NORTH AMERICA DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 9 NORTH AMERICA DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 10 NORTH AMERICA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 11 NORTH AMERICA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 12 NORTH AMERICA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)

TABLE 13 NORTH AMERICA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 14 NORTH AMERICA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 15 NORTH AMERICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 16 NORTH AMERICA VAPE PEN IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 17 NORTH AMERICA VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 18 NORTH AMERICA VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 19 NORTH AMERICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 20 NORTH AMERICA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 21 NORTH AMERICA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 22 NORTH AMERICA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 23 NORTH AMERICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 24 NORTH AMERICA CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 25 NORTH AMERICA CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 26 NORTH AMERICA CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 27 NORTH AMERICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 28 NORTH AMERICA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 29 NORTH AMERICA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 30 NORTH AMERICA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 31 NORTH AMERICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 32 NORTH AMERICA PATCH IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 33 NORTH AMERICA PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 34 NORTH AMERICA PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 35 NORTH AMERICA PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 36 NORTH AMERICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 37 NORTH AMERICA MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 38 NORTH AMERICA MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 39 NORTH AMERICA MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 40 NORTH AMERICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 41 NORTH AMERICA CLEANSER IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 42 NORTH AMERICA CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 43 NORTH AMERICA CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 44 NORTH AMERICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 45 NORTH AMERICA OTHERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 46 NORTH AMERICA MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 47 NORTH AMERICA SATIVA IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 48 NORTH AMERICA HYBRID IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 49 NORTH AMERICA CANNABIS INDICA IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 50 NORTH AMERICA MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)

TABLE 51 NORTH AMERICA CANNABIDIOL (CBD) IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 52 NORTH AMERICA TETRAHYDROCANNABINOL (THC)/DELTA-8-TETRAHYDROCANNABINOL IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 53 NORTH AMERICA CANNABIGEROL (CBG) IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 54 NORTH AMERICA CANNABICHROMENE (CBC) IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 55 NORTH AMERICA CANNABINOL (CBN) IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 56 NORTH AMERICA CANNABICYCLOL (CBL) IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 57 NORTH AMERICA OTHERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 58 NORTH AMERICA MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 59 NORTH AMERICA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 60 NORTH AMERICA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 61 NORTH AMERICA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 62 NORTH AMERICA ANXIETY IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 63 NORTH AMERICA ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 64 NORTH AMERICA MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 65 NORTH AMERICA MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 66 NORTH AMERICA NAUSEA IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 67 NORTH AMERICA NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 68 NORTH AMERICA APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 69 NORTH AMERICA APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 70 NORTH AMERICA EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 71 NORTH AMERICA EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 72 NORTH AMERICA INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 73 NORTH AMERICA INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 74 NORTH AMERICA CANCER IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 75 NORTH AMERICA CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 76 NORTH AMERICA ARTHRITIS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 77 NORTH AMERICA ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 78 NORTH AMERICA WASHING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 79 NORTH AMERICA WASHING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 80 NORTH AMERICA ALZHEIMER’S DISEASE IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 81 NORTH AMERICA ALZHEIMER’S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 82 NORTH AMERICA EPILEPSY IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 83 NORTH AMERICA EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 84 NORTH AMERICA DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 85 NORTH AMERICA DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 86 NORTH AMERICA MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 87 NORTH AMERICA MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 88 NORTH AMERICA AUTISM IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 89 NORTH AMERICA AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 90 NORTH AMERICA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 91 NORTH AMERICA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 92 NORTH AMERICA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 93 NORTH AMERICA ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 94 NORTH AMERICA ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 95 NORTH AMERICA OTHERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 96 NORTH AMERICA MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 97 NORTH AMERICA ORAL SOLUTIONS AND CAPSULES IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 98 NORTH AMERICA SMOKING IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 99 NORTH AMERICA TOPICALS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 100 NORTH AMERICA VAPORIZERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 101 NORTH AMERICA OTHERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 102 NORTH AMERICA MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)

TABLE 103 NORTH AMERICA ANALGESIC IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 104 NORTH AMERICA PSYCHEDELIC IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 105 NORTH AMERICA ANTIVIRAL IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 106 NORTH AMERICA APHRODISIAC IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 107 NORTH AMERICA EXPECTORANT IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 108 NORTH AMERICA OTHERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 109 NORTH AMERICA MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 110 NORTH AMERICA HOMECARE SETTING IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 111 NORTH AMERICA HOSPITAL IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 112 NORTH AMERICA REHAB CENTERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 113 NORTH AMERICA PHARMACEUTICAL INDUSTRY IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 114 NORTH AMERICA RESEARCH AND DEVELOPMENT CENTERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 115 NORTH AMERICA OTHERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 116 NORTH AMERICA MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 117 NORTH AMERICA B2C IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 118 NORTH AMERICA B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 119 NORTH AMERICA B2B IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 120 NORTH AMERICA MEDICAL CANNABIS MARKET, BY COUNTRY, 2021-2030 (USD MILLION)

TABLE 121 NORTH AMERICA MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 122 NORTH AMERICA OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 123 NORTH AMERICA OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 124 NORTH AMERICA OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 125 NORTH AMERICA OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 126 NORTH AMERICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 127 NORTH AMERICA DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 128 NORTH AMERICA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 129 NORTH AMERICA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)

TABLE 130 NORTH AMERICA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 131 NORTH AMERICA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 132 NORTH AMERICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 133 NORTH AMERICA VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 134 NORTH AMERICA VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 135 NORTH AMERICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 136 NORTH AMERICA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 137 NORTH AMERICA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 138 NORTH AMERICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 139 NORTH AMERICA CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 140 NORTH AMERICA CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 141 NORTH AMERICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 142 NORTH AMERICA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 143 NORTH AMERICA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 144 NORTH AMERICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 145 NORTH AMERICA PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 146 NORTH AMERICA PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 147 NORTH AMERICA PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 148 NORTH AMERICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 149 NORTH AMERICA MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 150 NORTH AMERICA MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 151 NORTH AMERICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 152 NORTH AMERICA CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 153 NORTH AMERICA CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 154 NORTH AMERICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 155 NORTH AMERICA MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 156 NORTH AMERICA SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 157 NORTH AMERICA MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 158 NORTH AMERICA MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)

TABLE 159 NORTH AMERICA MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 160 NORTH AMERICA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 161 NORTH AMERICA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 162 NORTH AMERICA ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 163 NORTH AMERICA MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 164 NORTH AMERICA NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 165 NORTH AMERICA APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 166 NORTH AMERICA EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 167 NORTH AMERICA INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 168 NORTH AMERICA CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 169 NORTH AMERICA ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 170 NORTH AMERICA WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 171 NORTH AMERICA ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 172 NORTH AMERICA EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 173 NORTH AMERICA DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 174 NORTH AMERICA MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 175 NORTH AMERICA AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 176 NORTH AMERICA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 177 NORTH AMERICA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 178 NORTH AMERICA ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 179 NORTH AMERICA MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 180 NORTH AMERICA MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)

TABLE 181 NORTH AMERICA MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 182 NORTH AMERICA MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 183 NORTH AMERICA B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 184 U.S. MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 185 U.S. OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 186 U.S. OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 187 U.S. OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 188 U.S. OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 189 U.S. BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 190 U.S. DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 191 U.S. MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 192 U.S. MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)

TABLE 193 U.S. MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 194 U.S. MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 195 U.S. BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 196 U.S. VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 197 U.S. VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 198 U.S. BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 199 U.S. WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 200 U.S. WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 201 U.S. BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 202 U.S. CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 203 U.S. CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 204 U.S. BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 205 U.S. GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 206 U.S. GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 207 U.S. BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 208 U.S. PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 209 U.S. PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 210 U.S. PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 211 U.S. BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 212 U.S. MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 213 U.S. MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 214 U.S. BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 215 U.S. CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 216 U.S. CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 217 U.S. BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 218 U.S. MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 219 U.S. SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 220 U.S. MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 221 U.S. MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)

TABLE 222 U.S. MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 223 U.S. PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 224 U.S. PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 225 U.S. ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 226 U.S. MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 227 U.S. NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 228 U.S. APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 229 U.S. EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 230 U.S. INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 231 U.S. CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 232 U.S. ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 233 U.S. WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 234 U.S. ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 235 U.S. EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 236 U.S. DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 237 U.S. MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 238 U.S. AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 239 U.S. MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 240 U.S. MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 241 U.S. ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 242 U.S. MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 243 U.S. MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)

TABLE 244 U.S. MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 245 U.S. MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 246 U.S. B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 247 CANADA MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 248 CANADA OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 249 CANADA OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 250 CANADA OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 251 CANADA OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 252 CANADA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 253 CANADA DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 254 CANADA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 255 CANADA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)

TABLE 256 CANADA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 257 CANADA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 258 CANADA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 259 CANADA VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 260 CANADA VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 261 CANADA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 262 CANADA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 263 CANADA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 264 CANADA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 265 CANADA CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 266 CANADA CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 267 CANADA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 268 CANADA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 269 CANADA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 270 CANADA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 271 CANADA PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 272 CANADA PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 273 CANADA PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 274 CANADA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 275 CANADA MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 276 CANADA MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 277 CANADA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 278 CANADA CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 279 CANADA CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 280 CANADA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 281 CANADA MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 282 CANADA SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 283 CANADA MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 284 CANADA MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)

TABLE 285 CANADA MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 286 CANADA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 287 CANADA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 288 CANADA ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 289 CANADA MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 290 CANADA NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 291 CANADA APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 292 CANADA EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 293 CANADA INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 294 CANADA CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 295 CANADA ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 296 CANADA WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 297 CANADA ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 298 CANADA EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 299 CANADA DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 300 CANADA MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 301 CANADA AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 302 CANADA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 303 CANADA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 304 CANADA ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 305 CANADA MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 306 CANADA MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)

TABLE 307 CANADA MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 308 CANADA MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 309 CANADA B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 310 MEXICO MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 311 MEXICO OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 312 MEXICO OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 313 MEXICO OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 314 MEXICO OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 315 MEXICO BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 316 MEXICO DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 317 MEXICO MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 318 MEXICO MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)

TABLE 319 MEXICO MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 320 MEXICO MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 321 MEXICO BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 322 MEXICO VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 323 MEXICO VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 324 MEXICO BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 325 MEXICO WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 326 MEXICO WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 327 MEXICO BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 328 MEXICO CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 329 MEXICO CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 330 MEXICO BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 331 MEXICO GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 332 MEXICO GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 333 MEXICO BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 334 MEXICO PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 335 MEXICO PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 336 MEXICO PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 337 MEXICO BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 338 MEXICO MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 339 MEXICO MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 340 MEXICO BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 341 MEXICO CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 342 MEXICO CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 343 MEXICO BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 344 MEXICO MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 345 MEXICO SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 346 MEXICO MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 347 MEXICO MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)

TABLE 348 MEXICO MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 349 MEXICO PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 350 MEXICO PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 351 MEXICO ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 352 MEXICO MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 353 MEXICO NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 354 MEXICO APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 355 MEXICO EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 356 MEXICO INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 357 MEXICO CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 358 MEXICO ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 359 MEXICO WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 360 MEXICO ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 361 MEXICO EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 362 MEXICO DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 363 MEXICO MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 364 MEXICO AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 365 MEXICO MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 366 MEXICO MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 367 MEXICO ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 368 MEXICO MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 369 MEXICO MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)

TABLE 370 MEXICO MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 371 MEXICO MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 372 MEXICO B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

図表一覧

FIGURE 1 NORTH AMERICA MEDICAL CANNABIS MARKET: SEGMENTATION

FIGURE 2 NORTH AMERICA MEDICAL CANNABIS MARKET: DATA TRIANGULATION

FIGURE 3 NORTH AMERICA MEDICAL CANNABIS MARKET: DROC ANALYSIS

FIGURE 4 NORTH AMERICA MEDICAL CANNABIS MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS

FIGURE 5 NORTH AMERICA MEDICAL CANNABIS MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 NORTH AMERICA MEDICAL CANNABIS MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 NORTH AMERICA MEDICAL CANNABIS MARKET: DBMR MARKET POSITION GRID

FIGURE 8 NORTH AMERICA MEDICAL CANNABIS MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 9 NORTH AMERICA MEDICAL CANNABIS MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 NORTH AMERICA MEDICAL CANNABIS MARKET: SEGMENTATION

FIGURE 11 INCREASING MEDICINAL USE AND LEGALIZATION OF MEDICAL CANNABIS ARE EXPECTED TO DRIVE THE NORTH AMERICA MEDICAL CANNABIS MARKET IN THE FORECAST PERIOD OF 2023 TO 2030

FIGURE 12 PRODUCT SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA MEDICAL CANNABIS MARKET IN 2023 AND 2030

FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE NORTH AMERICA MEDICAL CANNABIS MARKET AND IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2023 TO 2030

FIGURE 14 NORTH AMERICA IS THE FASTEST-GROWING MARKET FOR MEDICAL CANNABIS MANUFACTURERS IN THE FORECAST PERIOD OF 2023 TO 2030

FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE NORTH AMERICA MEDICAL CANNABIS MARKET

FIGURE 16 NORTH AMERICA MEDICAL CANNABIS MARKET: BY PRODUCT, 2022

FIGURE 17 NORTH AMERICA MEDICAL CANNABIS MARKET: BY PRODUCT, 2023-2030 (USD MILLION)

FIGURE 18 NORTH AMERICA MEDICAL CANNABIS MARKET: BY PRODUCT, CAGR (2023-2030)

FIGURE 19 NORTH AMERICA MEDICAL CANNABIS MARKET: BY PRODUCT, LIFELINE CURVE

FIGURE 20 NORTH AMERICA MEDICAL CANNABIS MARKET: BY SPECIES, 2022

FIGURE 21 NORTH AMERICA MEDICAL CANNABIS MARKET: BY SPECIES, 2023-2030 (USD MILLION)

FIGURE 22 NORTH AMERICA MEDICAL CANNABIS MARKET: BY SPECIES, CAGR (2023-2030)

FIGURE 23 NORTH AMERICA MEDICAL CANNABIS MARKET: BY SPECIES, LIFELINE CURVE

FIGURE 24 NORTH AMERICA MEDICAL CANNABIS MARKET: BY DERIVATIVES, 2022

FIGURE 25 NORTH AMERICA MEDICAL CANNABIS MARKET: BY DERIVATIVES, 2023-2030 (USD MILLION)

FIGURE 26 NORTH AMERICA MEDICAL CANNABIS MARKET: BY DERIVATIVES, CAGR (2023-2030)

FIGURE 27 NORTH AMERICA MEDICAL CANNABIS MARKET: BY DERIVATIVES, LIFELINE CURVE

FIGURE 28 NORTH AMERICA MEDICAL CANNABIS MARKET: BY APPLICATION, 2022

FIGURE 29 NORTH AMERICA MEDICAL CANNABIS MARKET: BY APPLICATION , 2023-2030 (USD MILLION)

FIGURE 30 NORTH AMERICA MEDICAL CANNABIS MARKET: BY APPLICATION , CAGR (2023-2030)

FIGURE 31 NORTH AMERICA MEDICAL CANNABIS MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 32 NORTH AMERICA MEDICAL CANNABIS MARKET: BY ROUTE OF ADMINISTRATION, 2022

FIGURE 33 NORTH AMERICA MEDICAL CANNABIS MARKET: BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)

FIGURE 34 NORTH AMERICA MEDICAL CANNABIS MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2023-2030)

FIGURE 35 NORTH AMERICA MEDICAL CANNABIS MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE

FIGURE 36 NORTH AMERICA MEDICAL CANNABIS MARKET: BY TREATMENT TYPE, 2022

FIGURE 37 NORTH AMERICA MEDICAL CANNABIS MARKET: BY TREATMENT TYPE, 2023-2030 (USD MILLION)

FIGURE 38 NORTH AMERICA MEDICAL CANNABIS MARKET: BY TREATMENT TYPE, CAGR (2023-2030)

FIGURE 39 NORTH AMERICA MEDICAL CANNABIS MARKET: BY TREATMENT TYPE, LIFELINE CURVE

FIGURE 40 NORTH AMERICA MEDICAL CANNABIS MARKET: BY END USER, 2022

FIGURE 41 NORTH AMERICA MEDICAL CANNABIS MARKET: BY END USER, 2023-2030 (USD MILLION)

FIGURE 42 NORTH AMERICA MEDICAL CANNABIS MARKET: BY END USER, CAGR (2023-2030)

FIGURE 43 NORTH AMERICA MEDICAL CANNABIS MARKET: BY END USER, LIFELINE CURVE

FIGURE 44 NORTH AMERICA MEDICAL CANNABIS MARKET: BY DISTRIBUTION CHANNEL, 2022

FIGURE 45 NORTH AMERICA MEDICAL CANNABIS MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)

FIGURE 46 NORTH AMERICA MEDICAL CANNABIS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)

FIGURE 47 NORTH AMERICA MEDICAL CANNABIS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 48 NORTH AMERICA MEDICAL CANNABIS MARKET: SNAPSHOT (2022)

FIGURE 49 NORTH AMERICA MEDICAL CANNABIS MARKET: BY COUNTRY (2022)

FIGURE 50 NORTH AMERICA MEDICAL CANNABIS MARKET: BY COUNTRY (2023 & 2030)

FIGURE 51 NORTH AMERICA MEDICAL CANNABIS MARKET: BY COUNTRY (2022 & 2030)

FIGURE 52 NORTH AMERICA MEDICAL CANNABIS MARKET: BY PRODUCT (2023-2030)

FIGURE 53 NORTH AMERICA MEDICAL CANNABIS MARKET: COMPANY SHARE 2022 (%)

詳細情報を見る Right Arrow

調査方法

データ収集と基準年分析は、大規模なサンプル サイズのデータ​​収集モジュールを使用して行われます。この段階では、さまざまなソースと戦略を通じて市場情報または関連データを取得します。過去に取得したすべてのデータを事前に調査および計画することも含まれます。また、さまざまな情報ソース間で見られる情報の不一致の調査も含まれます。市場データは、市場統計モデルと一貫性モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせをドロップダウンしてください。

DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数が市場に与える影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、特許分析、価格分析、企業市場シェア分析、測定基準、グローバルと地域、ベンダー シェア分析が含まれます。調査方法について詳しくは、お問い合わせフォームから当社の業界専門家にご相談ください。

カスタマイズ可能

Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合致し、それに適したデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、リファービッシュ市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社のデータを、必要な形式とデータ スタイルでいくつでも追加できます。当社のアナリスト チームは、粗い生の Excel ファイル ピボット テーブル (ファクト ブック) でデータを提供したり、レポートで利用可能なデータ セットからプレゼンテーションを作成するお手伝いをしたりすることもできます。

Frequently Asked Questions

The North America Medical Cannabis Market is projected to grow at a CAGR of 23.2% during the forecast period by 2030.
The North America Medical Cannabis Market is segmented on the basis of product, source, species, derivatives, application, route of administration, treatment type, end user, and distribution channel.
The major players in the North America Medical Cannabis Market are MediPharm Labs Inc., Tilray, Aurora Cannabis, JAZZ Pharmaceuticals Inc. (GW Pharmaceuticals plc), HEXO Corp. (Zenabis Global Ltd), Cresco Labs, Peace Naturals Project Inc., CANOPY GROWTH CORPORATION, etc.
The countries covered in the North America Medical Cannabis Market are U.S., Canada, and Mexico.